Latent tuberculosis infection: the 4-month course of rifampicin is safer than the 9-month course of isoniazid ( Jonathon R Campbellet al )
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials
| Pr Pierre Tattevin Different regimens have similar efficacy for the treatment of latent tuberculosis infection (LTI), including 3 months of isoniazid (INH)/rifampicin (RMP), … Suite